全球基因合成软件市场 – 行业趋势和 2030 年预测

基因合成软件市场分析及规模

有证据表明，政府对合成生物学的支持政策是市场的主要驱动因素。科学界正在探索该领域尚未开发的途径，从而带来收入增长。传统的克隆和诱变方法正在迅速被从头基因合成所取代，这也允许核酸生产。

Data Bridge Market Research分析，基因合成软件市场预计到2030年将达到57.5亿美元，到2022年为14.7亿美元，预计在2022年至2030年的预测期内复合年增长率为18.6%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

基因合成软件市场范围和细分

Market Definition

Gene synthesis is the process of generating artificial genes in a lab setting with the help of synthetic biology. The generation of recombinant proteins is one of the several applications of recombinant DNA technology, wherein the gene synthesis is developing as a major instrument

Gene Synthesis Software Market Dynamics

Drivers

• Increasing demand of solid-phase synthesis

The solid-phase synthesis came into much limelight in recent years. The high accuracy of this method boosts its disposition among therapy developers and research settings. Though, its high cost and low output hamper its usage in some cases, are creating much opportunities for other methods. PCR- and other chip-based methods are projected to show major CAGRs during the forecast period. These methods permit the synthesis of larger fragments at a much lower rate, leading to their increased usage. Additionally, the PCR-based method offers high accuracy of the gene sequence using cell systems.

• High use of personalized medicine

Growing demand for personalized medicines has led the way for genomics that demands the error-free gene sequences at a much low cost in a very short period, therefore acts as an opportunity for the gene synthesis market. 

Opportunities

• Increased clinical research and technological advancement

The diverse advances in synthetic DNA technology are attracting much attraction as a feasible measure to address issues associated with the increasing number of developing pathogens and the threats of the next global pandemic. This strategy became helpful in responding quickly to the SARS-CoV-2 pandemic along with the near-future pandemics involving other novel pathogens.Thus, this boost the market growth. In the last few decades, targeted therapy is in much use by researchers as well as by biotechnology and pharmaceutical companies. It has developed as an important way of disease management. This therapy along with chemotherapy and immunotherapy is anticipated to witness major growth in the near future, which in turn, is creating much opportunities for the developing players in the market.

Restraints/Challenges

• Huge cost of diagnostic tests

Several tests are widely available for testing cardiovascular, chronic diseases, and other conditions such as diabetes. But these tests are of heavy cost which many patients can't afford, particularly those belonging to the lower economic groups. Therefore, it hampers the market growth.

• Lack of skilled professionals

A scarcity of skilled professionals in the field of gene synthesis and biotechnology is a major obstacle for the market growth, as the key market players require trained and experienced staff at their facilities. Therefore, several companies are now partnering with numerous universities and offering on-site training, online workshops, and sponsored projects to hugely develop the right professionals, thus boosting the market growth

This gene synthesis software market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gene synthesis software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Gene Synthesis Software Market

The COVID-19 pandemic has benefited the market, with respect to new growth opportunities. Several scientific communities are discovering untapped avenues in the space, thus leading to higher revenue growth. For instance, researchers at the National Institute of Standards and Technology (NIST) have developed synthetic gene fragments from the COVID-19 virus to help different  diagnostic developers to launch more accurate and reliable diagnostic tests for the disease

Recent Developments

In 2020, Twist Bioscience launched clonal-ready gene fragments in order to complete the offering of genes. These fragments can be used with or without adapters to build up the perfect clones. The clonal-ready gene fragments are compatible with the enzyme engineering, and gene expression, protein expression pathways, among others.

Global Gene Synthesis Software Market Scope

The gene synthesis software market is segmented on the basis of applications, synthesis type, method, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Research and Development Activities
• Diagnostics
• Therapeutics
• Others

Synthesis Type

• Gene Library Synthesis
• Custom Gene Synthesis

Method

• Solid Phase Synthesis
• Chip-Based DNA Synthesis
• PCR-Based Enzyme Synthesis

End-user

• Hospital and Clinics
• Diagnostic Laboratories
• Others

Gene Synthesis Software Regional Analysis/Insights

The gene synthesis software market is analyzed and market size insights and trends are provided by applications, synthesis type, method and end-user as referenced above.

The countries covered in the gene synthesis software market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the gene synthesis software market due to the growing demand from the academic institutes and biopharmaceutical companies with occurrence of numerous market players in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing levels of investment for synthetic biology and the incidence of private companies in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The gene synthesis software market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for gene synthesis software market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gene synthesis software market. The data is available for historic period 2011-2020.

Competitive Landscape and Global Gene Synthesis Software Market Share Analysis

基因合成软件市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对基因合成软件市场的关注有关。

基因合成软件市场的一些主要参与者包括：

• 金斯瑞 (中国)
• Sangamo Therapeutics（美国）
• Eurofins Genomics（日本）
• ATDBio Ltd（美国）
• BIONEER CORPORATION。（韩国）
• Kaneka Eurogentec SA（比利时）
• 金唯智德国有限公司（德国）
• Twist Bioscience（美国）
• 合成基因组学（美国）
• Codexis Inc.（美国）
•  Synthego（美国）
• Creative Enzymes（美国）
• Eurofins Scientific（卢森堡）
• Cyrus Biotechnology Inc.（美国）
• ATUM（美国）
• TeselaGen（美国）
• Arzeda（美国）
• Integrated DNA Technologies Inc.（美国）
• 新英格兰生物实验室（美国）
• Genome Medical, Inc.（美国）
• BioMed Central Ltd（英国）

SKU-57117